Fifth Third Bancorp
SNDX icon

Fifth Third Bancorp’s Syndax Pharmaceuticals SNDX Stock Holding History

Fifth Third Bancorp’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.3K Buy
+998
New +$21.7K ﹤0.01% 3454

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fifth Third Bancorp's SNDX Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 998 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #3454 among its holdings.

246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Fifth Third Bancorp held 998 shares of Syndax Pharmaceuticals worth $23.3K as of Q1 2026.
  • Syndax Pharmaceuticals was a new Fifth Third Bancorp position in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3454 holding.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.